Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: A systematic review

References

• AMD Alliance International. (2010). The global economic cost of visual impairment. Australia: Access Economics.
   Google Scholar
• Avci, R., Inan, S., Polat, O., Kusbeci, T., Yavas, G., & Dogan, M. (2013). Non-compliance to the intravitreal anti-VEGF injections in patients with exudative age-related macular degeneration. Paper presented at the ASRS 31st Annual Meeting, Toronto.
   Google Scholar
• Berdeaux, G., Nordmann, J., Colin, E., & Arnould, B. (2005). Vision-related quality of life in patients suffering from age-related macular degeneration. American Journal of Ophthalmology, 139, 271–279.10.1016/j.ajo.2004.09.028
   PubMed Web of Science ®Google Scholar
• Blaha, G., Tilton, E., Barouch, F., & Marx, J. (2011). Randomized trial of anesthetic methods for intravitreal injections. Retina, 31, 535–539. doi:10.1097/IAE.0b013e3181eac724.10.1097/IAE.0b013e3181eac724
   PubMed Web of Science ®Google Scholar
• Brody, B., Gamst, A., Williams, R., Smith, A., Lau, P., Dolnak, D., … Kaplan, R. M. (2001). Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology, 108, 1893–1900.10.1016/S0161-6420(01)00754-0
   PubMed Web of Science ®Google Scholar
• Cahill, M., Banks, A., Stinnett, S., & Toth, C. (2005). Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152–158.10.1016/j.ophtha.2004.06.036
   PubMed Web of Science ®Google Scholar
• Chua, P., Mitrut, I., Armbrecht, A., Vani, A., Aslam, T., & Dhillon, B. (2009). Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration. Archives of Ophthalmology, 127, 939–940.
   PubMed Web of Science ®Google Scholar
• Coleman, H., Chan, C., Ferris, F., & Chew, E. (2008). Age-related macular degeneration. The Lancet, 372, 1835–1845.10.1016/S0140-6736(08)61759-6
   PubMed Web of Science ®Google Scholar
• Dong, L., Childs, A., Mangione, C., Bass, E., Bressler, N., Hawkins, B., … McCaffrey, L. (2004). Health-and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery. American Journal of Ophthalmology, 138, 91.
   PubMed Web of Science ®Google Scholar
• Hassell, J., Lamoureux, E., & Keeffe, J. (2006). Impact of age related macular degeneration on quality of life. British Journal of Ophthalmology, 90, 593–596.10.1136/bjo.2005.086595
   PubMed Web of Science ®Google Scholar
• Henriksen, K., & Adhami, S. (2010). Patient experience of intravitreal injections in AMD. International Journal of Ophthalmic Practice, 1, 68–72.10.12968/ijop.2010.1.2.68
   Google Scholar
• LaHood, B., Sherwood, D., & Suter, A. (2011). Comparative assessment of the effectiveness of anaesthesia for intravitreal bevacizumab injection. Clinical and Experimental Ophthalmology, 39, 184–185. doi:10.1111/j.1442-9071.2010.02432.x.10.1111/ceo.2011.39.issue-2
   PubMed Web of Science ®Google Scholar
• Macular Degeneration Foundation. (2011). Eyes on the future: A clear outlook on age-related macular degeneration (D. A. Economics, Ed.). Australia: Deloitte Access Economics.
   Google Scholar
• Mitchell, J., & Bradley, C. (2006). Quality of life in age-related macular degeneration: A review of the literature. Health and Quality of Life Outcomes, 4, 97.10.1186/1477-7525-4-97
   PubMed Web of Science ®Google Scholar
• Moisseiev, E., Regenbogen, M., Bartfeld, Y., & Barak, A. (2012). Evaluation of pain in intravitreal bevacizumab injections. Current Eye Research, 37, 813–817. doi:10.3109/02713683.2012.681335.10.3109/02713683.2012.681335
   PubMed Web of Science ®Google Scholar
• Nijkamp, M., Kenens, C., Dijker, A., Ruiter, R., Hiddema, F., & Nuijts, R. (2004). Determinants of surgery related anxiety in cataract patients. British Journal of Ophthalmology, 88, 1310–1314.10.1136/bjo.2003.037788
   PubMed Web of Science ®Google Scholar
• Pager, C. (2005). Randomised controlled trial of preoperative information to improve satisfaction with cataract surgery. British Journal of Ophthalmology, 89, 10–13.10.1136/bjo.2004.048637
   PubMed Web of Science ®Google Scholar
• Rifkin, L., & Schaal, S. (2012). Factors affecting patients’ pain intensity during in office intravitreal injection procedure. Retina, 32, 696–700. doi:10.1097/IAE.0b013e3182252ad3.10.1097/IAE.0b013e3182252ad3
   PubMed Web of Science ®Google Scholar
• Roth, D., Scott, I., Gulati, N., & Prenner, J. (2006). Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection. American Journal of Ophthalmology, 142, 492–494.10.1016/j.ajo.2006.03.042
   PubMed Web of Science ®Google Scholar
• Rovner, B., & Casten, R. (2002). Activity loss and depression in age-related macular degeneration. The American Journal of Geriatric Psychiatry, 10, 305–310.10.1097/00019442-200205000-00010
   PubMed Web of Science ®Google Scholar
• Royal College of Ophthalmologists. (2013). Age-related macular degeneration: Guidelines for management. London: The Royal College of Ophthalmologists.
   Google Scholar
• Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C., Klein, B., … Jensen, S. (2001). Risk factors for age-related macular degeneration. Ophthalmology, 108, 697–704.10.1016/S0161-6420(00)00580-7
   PubMed Web of Science ®Google Scholar
• Stevenson, M., Hart, P., Montgomery, A., McCulloch, D., & Chakravarthy, U. (2004). Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. British Journal of Ophthalmology, 88, 1125–1130.10.1136/bjo.2003.032383
   PubMed Web of Science ®Google Scholar
• Tailor, R., Beasley, R., Yang, Y., & Narendran, N. (2011). Evaluation of patients’ experiences at different stages of the intravitreal injection procedure – What can be improved? Clinical Ophthalmology, 5, 1499.10.2147/OPTH
   PubMedGoogle Scholar
• Thetford, C., Hodge, S., Harding, S., Taylor, S., & Knox, P. (2013). Living with age-related macular degeneration treatment: Patient experiences of being treated with ranibizumab (Lucentis)® intravitreal injections. British Journal of Visual Impairment, 31, 89–101.10.1177/0264619613481778
   Google Scholar
• Trento, M., Tomelini, M., Lattanzio, R., Brancato, R., Coggiola, A., Benecchi, R., … Insacco, C. (2006). Perception of, and anxiety levels induced by, laser treatment in patients with sight-threatening diabetic retinopathy: A multi-centre study. Diabetic Medicine, 23, 1106–1109.10.1111/dme.2006.23.issue-10
   PubMed Web of Science ®Google Scholar
• Wong, T., Chakravarthy, U., Klein, R., Mitchell, P., Zlateva, G., Buggage, R., … Probst, C. (2008). The natural history and prognosis of neovascular age-related macular degeneration: A systematic review of the literature and meta-analysis. Ophthalmology, 115, 116–126.10.1016/j.ophtha.2007.03.008
   PubMed Web of Science ®Google Scholar
• Yau, G., Jackman, C., Hooper, P., & Sheidow, T. (2011). Intravitreal injection anesthesia – Comparison of different topical agents: A prospective randomized controlled trial. American Journal of Ophthalmology, 151, 333–337.e2 e332. doi: 10.1016/j.ajo.2010.08.03110.1016/j.ajo.2010.08.031
   PubMed Web of Science ®Google Scholar